Sean Nolan

Overview

Sean Nolan received an average of $2M in total compensation, including $313K in salary, at Taysha Gene Therapies between 2022 and 2023.

Source: SEC filings on April 18, 2024 and May 8, 2023.

Related executives

We found four more executives who work or worked at Taysha Gene Therapies.

Sukumar Nagendran

Taysha Gene Therapies

President and Head of Research and Development

Kamran Alam

Taysha Gene Therapies

Chief Financial Officer

RA Session

Taysha Gene Therapies

Chief Executive Officer

Suyash FFPM

Taysha Gene Therapies

Chief Medical Officer

News

You may also like